<DOC>
	<DOCNO>NCT02139826</DOCNO>
	<brief_summary>The purpose study compare absorption blood level IX-01 give capsule compare liquid form , food affect absorption healthy men .</brief_summary>
	<brief_title>Relative Bioavailability Food Effect Study IX-01 Capsules Healthy Men</brief_title>
	<detailed_description />
	<criteria>A body mass index ( Quetelet index ) range 1830 kilograms/meters square ( kg/m2 ) Body Mass Index = weight [ kg ] divide ( height [ ] ) 2 Total body weight great ( &gt; ) 50 kg screen Ability communicate satisfactorily investigator participate , comply requirement , entire trial Participants partner must willing use adequate form contraception comply contraception requirement trial 4 month last dose medication Willingness give write consent data enter The Over Volunteering Prevention System Clinically relevant abnormal history , physical finding , ECG , laboratory value pretrial screen assessment , include : Lipid and/or liver function test result &gt; 1.25 x Upper Limit Normal ( ULN ) clinical laboratory blood biochemistry test result outside normal reference range unless discuss approve sponsor International normalise ratio ( INR ) &gt; 1.2 platelet count &lt; 150 x 109/Liter History unexplained syncope Family history unexplained sudden death , sudden death due long QT syndrome Fridericia Correction Formula ( QTcF ) interval &gt; 450 millisecond ( msec ) screen Bundle branch block conduction abnormality , mild first degree atrioventricular block Irregular rhythm sinus arrhythmia occasional supraventricular ectopic beat Twave configuration insufficient quality determination QT interval , assess investigator Presence acute chronic illness history chronic illness sufficient invalidate participation trial Impaired gastrointestinal , endocrine , thyroid , hepatic , cardiovascular , respiratory , haematological , renal neurological function , diabetes mellitus , coronary heart disease , history psychotic mental illness Surgery ( example ( e.g . ) stomach bypass ) medical condition might affect absorption , metabolism elimination medicine Any skin condition , abnormality lumbar spine , medical surgical condition would preclude lumbar puncture ( e.g . coagulopathy , local systemic infection , leave ventricular outflow obstruction , aortic stenosis , previous back surgery ) Presence history severe adverse reaction drug Use prescription overthecounter medicine 14 day first dose trial medication , intention use medicine trial , exception short course medication consider investigator interfere safety participant integrity trial data ( acetaminophen ( paracetamol ) ) Current use herbal remedy nutritional supplement , intention use product study Participation another clinical trial new chemical entity prescription medicine within previous 3 month . Previous participation trial clinical trial oxytocin receptor antagonist Presence history drug alcohol abuse , intake 21 unit alcohol weekly 5 cigarette daily Blood pressure heart rate supine position screen examination outside range 100130 millimeter mercury ( mm Hg ) systolic , 6090 mm Hg diastolic ; heart rate 50100 beats/minute . Measurements must make duplicate , value must fall within acceptable range Possibility participant cooperate requirement protocol Evidence drug abuse urine test Positive test hepatitis B , hepatitis C , Human Immunodeficiency Virus 1 ( HIV1 ) Human Immunodeficiency Virus 2 ( HIV2 ) Loss 400 mL blood 3 month trial , e.g . blood donor Objection General Practitioner ( GP ) , medical ground , participant enter trial Employee investigator site company involve sponsoring , organize conduct trial , immediate family employee</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>